A binding agent containing monolithic solid material having a binding agent evenly dispersed throughout a monolithic solid material, wherein the binding agent is not chemically coupled to the monolithic solid material, wherein {TAIL ~ the binding agent} comprises a lipid or phospholipid, and wherein the binding agent containing monolithic solid material binds to antibodies associated with a condition selected from the group consisting of {HEAD ~ systemic lupus erythematosus}, venus thrombosis, recurrent arterial thrombosis, recurrent spontaneous abortion, thrombocytopenia, chorea, epilepsy, livedo, idiopathic pulmonary hypertension, rheumatological conditions and collagenous diseases 
A binding agent containing monolithic solid material having a binding agent evenly dispersed throughout a monolithic solid material , wherein the binding agent is not chemically coupled to the monolithic solid material , wherein { TAIL ~ the binding agent } comprises a lipid or phospholipid , and wherein the binding agent containing monolithic solid material binds to antibodies associated with a condition selected from the group consisting of { HEAD ~ systemic lupus erythematosus } , venus thrombosis , recurrent arterial thrombosis , recurrent spontaneous abortion , thrombocytopenia , chorea , epilepsy , livedo , idiopathic pulmonary hypertension , rheumatological conditions and collagenous diseases
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH